Cargando…
Refining immunotherapeutic approaches to high‐risk neuroblastoma based on tumor genomic profiles
In this issue, Coronado et al. attempt to improve our understanding of the factors affecting the response to immunotherapy in a large subset of high‐risk neuroblastoma with hemizygous deletion of chromosome 11q. By using several computational approaches, the authors study potential transcriptional a...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7858281/ https://www.ncbi.nlm.nih.gov/pubmed/33314654 http://dx.doi.org/10.1002/1878-0261.12880 |